BR9806250A - Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases. - Google Patents
Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases.Info
- Publication number
- BR9806250A BR9806250A BR9806250-6A BR9806250A BR9806250A BR 9806250 A BR9806250 A BR 9806250A BR 9806250 A BR9806250 A BR 9806250A BR 9806250 A BR9806250 A BR 9806250A
- Authority
- BR
- Brazil
- Prior art keywords
- therapy
- isolated
- combination
- busesonde
- liver diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: <B>"BUDESONIDA ISOLADA OU EM COMBINAçãO COM áCIDO URSODESOXICóLICO NA TERAPIA DE DOENçAS HEPáTICAS COLESTáTICAS"<D>. De acordo com a invenção, verificou-se inesperadamente que a budesonida pode ser usada para o tratamento de doenças hepáticas colestáticas, como CBP, CEP e CA. Em particular, a budesonida é altamente eficaz quando juntamente com ácido ursodesoxicólico.Invention Patent: <B> "BUDESONIDE ISOLATED OR IN COMBINATION WITH URSODESOXICOLIC ACID IN THE THERAPY OF CHOLESTATIC HEPATIC DISEASES" <D>. According to the invention, it has unexpectedly been found that budesonide can be used for the treatment of cholestatic liver diseases, such as CBP, CEP and CA. In particular, budesonide is highly effective when combined with ursodeoxycholic acid.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE29717252U DE29717252U1 (en) | 1997-09-26 | 1997-09-26 | Drug kit consisting of a budesonide-containing and an ursodeoxycholic acid-containing drug for the treatment of cholestatic liver diseases |
| DE19742612A DE19742612A1 (en) | 1997-09-26 | 1997-09-26 | Budesonide for the treatment of cholestatic liver diseases |
| US08/940,211 US5858998A (en) | 1997-09-26 | 1997-09-30 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
| CA002216887A CA2216887C (en) | 1997-09-26 | 1997-09-30 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
| PCT/EP1998/005567 WO1999016429A2 (en) | 1997-09-26 | 1998-09-02 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9806250A true BR9806250A (en) | 2000-01-25 |
Family
ID=27427393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9806250-6A BR9806250A (en) | 1997-09-26 | 1998-09-02 | Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases. |
Country Status (2)
| Country | Link |
|---|---|
| BR (1) | BR9806250A (en) |
| WO (1) | WO1999016429A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3760203A1 (en) * | 2019-07-03 | 2021-01-06 | Medizinische Universität Graz | Medicament for prevention or treatment of a metabolic disorder |
-
1998
- 1998-09-02 WO PCT/EP1998/005567 patent/WO1999016429A2/en active Application Filing
- 1998-09-02 BR BR9806250-6A patent/BR9806250A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999016429A2 (en) | 1999-04-08 |
| WO1999016429A3 (en) | 2001-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0411319A (en) | therapeutically active compounds and their use | |
| BR0012666A (en) | Imidazoimidazoles and triazoles as anti-inflammatory agents | |
| BRPI0411295A (en) | compounds and their use in therapy | |
| BR9915943A (en) | Controlled release formulation comprising gnrh-ii | |
| BR0312845A (en) | Tetrapropylammonium tetrathiomolybdate and related compounds for antiangiogenic therapies | |
| DE60111539D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A 5-AMINOLAEVULIC ACID ESTER AS PHOTOCHEMOTHERAPEUTIC AND A MUCOADHESIS | |
| BR9714059A (en) | S-omeprazole in a neutral form, process to prepare it, use of it, pharmaceutical composition, and process to treat a condition related to gastric acid. | |
| CA2216887A1 (en) | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases | |
| BR9911071A (en) | Preparations for the application of anti-inflammatory agents, especially antiseptics and / or agents that promote healing of wounds in the upper respiratory tract and / or the ear | |
| BRPI0414876A (en) | pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses | |
| PT956009E (en) | TREATMENT OF NEURODEGENERATIVE DISEASES WITH NIMESULIDE | |
| BR9909908A (en) | Bile acid fatty acid derivatives and bile acid derivatives | |
| ECSP045520A (en) | TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS | |
| PA8657201A1 (en) | COMPOUNDS OF 3H-OXAZOLO AND 3H-TIAZOLO [4, 5-D] PIRIMIDIN-2-ONA 3, 5-DISUSTITUED AND 3, 5, 7 - TRISUSTITUIDA AND PROFARMACOS OF THE SAME | |
| BR9912179A (en) | Neuroprotective composition for the prevention and / or treatment of nervous and behavioral changes due to states of anxiety or depression | |
| UY28931A1 (en) | USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
| BR9711194A (en) | Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease. | |
| BR0107157A (en) | Diagnosis and treatment of cardiovascular conditions | |
| BR9914044A (en) | tetrahydropyride esters | |
| BR9810520A (en) | Factor xa inhibitor alone or in combination with an anti-platelet aggregator, against arterial thrombosis | |
| MY137766A (en) | Exemestane as chemopreventing agent | |
| BRPI0410326A (en) | composition comprising a pde4 inhibitor and pde5 inhibitor | |
| BR0008254A (en) | Combinations for the treatment of diseases involving angiogenesis | |
| BRPI0415753A (en) | method for treating and preventing respiratory inflammation with a cyclooxygenase-2 inhibitor in combination with a phosphodiesterase 4 inhibitor and compositions containing them | |
| BR9806892A (en) | New formulation for inhalation; showing volumetric density, when poured, from 0.20 to 038 g / ml, comprising budesonide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal |
Free format text: INDEFIRO PELO PRESENTE PEDIDO DE PATENTE DE ACORDO COM ARTIGO 8O DA LPI. |